The new coronavirus vaccine comes from American biotech company Moderna and has been tested on 30,000 people in the US, yielding safe results. Interim data released on Monday shows that the new vaccine has an affectivity of 94.5 percent. Moderna said it will continue its large scale trial until 151 cases have been reached, so far only 90 volunteers have taken the vaccine, and intends to submit the jab for an Emergency Use Authorisation (EUA) with us regulators “in the coming weeks”.
CEO of Moderna Stephane Bancal said the development marked a “pivotal moment”.
Mr Bancal said: “This positive interim analysis from our phase-three study has given us the first clinical validate that our vaccine can prevent COVID-19 disease, including severe disease.
“This milestone is only possible because of the hard work and sacrifices of so many.”
Downing Street added: “The news from Moderna appears to be good and represents another significant step towards finding an effective COVID-19 vaccine.”
READ MORE: Who owns Moderna? Latest coronavirus update as new vaccine gives hope
Vaccines often contain preservatives and stabilisers too to help keep the dose clean and effective.
These ingredients are often already found in the body or in food at much, much, higher levels than in a vaccine so recipients can be assured they don’t harm you in any way.
Just like in food, preservatives are used to ward off unwanted contamination and to stop them from spoiling.
Vaccine ingredients may have unfamiliar names and seem appear to be intimidating, but they are all ingredients that can be found in your body, food and in the world around you.
It is crucial to understand that all these ingredients, when used in small doses and created by scientific professionals, are safe and highly necessary to ensure a vaccine is of good quality.